NOVO NORDISK B

New Oral Wegovy Pill Gets FDA & EMA Approval – Boosts Novo Nordisk’s Weight‑Management Market

Novo Nordisk’s first oral GLP‑1 weight‑management pill, Wegovy® pill, hits FDA and EMA approvals, expands to India, and could shift its stock outlook.

22/12/2025, 23:58

3 minutes to read

Novo Nordisk B Announces Major Board Overhaul Amid Governance Dispute with Novo Nordisk Foundation

Novo Nordisk B, a leading Danish pharmaceutical company, is undergoing a major governance overhaul after a prolonged dispute with its primary shareholder, the Novo Nordisk Foundation, over the future composition and strategic direction of the board.

21/10/2025, 15:00

3 minutes to read

Novo Nordisk Shares Tumble Amid U.S. Drug Pricing Policy Changes and FDA Approval of Rybelsus

Novo Nordisk’s stock price plummeted 6.4% after former US President Donald Trump announced a plan to reduce tariffs on fertility treatments and the medication Ozempic, potentially undermining the company’s pricing power in the US market.

19/10/2025, 23:40

2 minutes to read